What is Invoy?
Invoy specializes in advancing metabolic health through innovative breath chemistry analysis. Leveraging patented technology, the company provides real-time insights into fat burn and overall metabolic function. Its integrated offerings include a proprietary breath device, a user-friendly mobile application, and personalized coaching services. These tools are designed to empower individuals, including doctors and health-conscious consumers, to effectively track their metabolism, manage weight, and make data-driven health decisions. Invoy's mission is to foster lifelong wellness by enabling users to understand the connection between their daily habits and metabolic outcomes.
How much funding has Invoy raised?
Invoy has raised a total of $898K across 1 funding round:
Private Equity
$898K
Private Equity (2009): $898K, investors not publicly disclosed
What's next for Invoy?
With the infusion of $898K in total capital and a recent strategic investment of $898K, Invoy is well-positioned for accelerated growth. The company is expected to further refine its patented breath analysis technology and expand its service offerings. This strategic financing will likely support enhanced research and development, broader market penetration, and the scaling of its personalized coaching programs. Invoy's focus on actionable metabolic insights aims to solidify its position as a leader in the preventative health and wellness technology space.
See full Invoy company page
